SanjivSModiMD

Oncology • Michigan City, IN

Physician

Join to view full profile

Dr. Modi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Modi's full profile

Already have an account?

Office
8955 W 400 N
Michigan City, IN 46360
Phone+1 219-861-5800

Fax+1 219-861-5543

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1994 - 1997
Baroda Medical CollegeClass of 1991

Certifications & Licensure

IL State Medical License 1994 - 2026
IN State Medical License 2024 - 2025
WA State Medical License 2023 - 2024
MN State Medical License 2023 - 2023
FL State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
National Merit Scholarship Government of India

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Active, not recruiting
Phase 1, Phase 2
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2007 Aug 01
Terminated
Phase 3
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2008 Jun 01
Completed
Phase 1
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
Completed
Phase 2
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2010 Sep 21
Active, not recruiting
Phase 2
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

154 citations
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin
Journal of Clinical Oncology. 2010-11-01
214 citations
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes
Roger M. Lyons, Thomas Cosgriff, Sanjiv Modi, Robert H. Gersh, John D. Hainsworth
Journal of Clinical Oncology. 2009-04-10
39 citations
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
Manish R. Sharma, Kristen Wroblewski, Blase N. Polite, James A. Knost, James A. Wallace
Investigational New Drugs. 2012-06-01

Journal Articles

Walter M Stadler, David J Vaughn, Guru Sonpavde, Nicholas J Vogelzang, Scott T Tagawa, Daniel P Petrylak, Peter Rosen, Chia-Chi Lin, John Mahoney, Sanjiv Modi, Peter L..., Cancer, 1/11/2014
Manish R Sharma, Kristen Wroblewski, Blase N Polite, James A Knost, James A Wallace, Sanjiv Modi, Bethany G Sleckman, David Taber, Everett E Vokes, Walter M Stadler, H..., Invest New Drugs, 1/1/2012
Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott Smith, Patrick Stiff, Eric Lester, Sanjiv Modi, L. Austin Doyle..., Journal of Clinical Oncology, 1/1/2010
Roger M. Lyons, Thomas M. Cosgriff, Sanjiv S. Modi, Robert H. Gersh, John D. Hainsworth, Allen L. Cohn, Heidi J. McIntyre, Indra J. Fernando, Jay T. Backstrom, C.L. Beach, Journal of Clinical Oncology, 1/1/2009
Yazan Alsayed, Sanjiv Modi, Shahab Uddin, Nadim Mahmud, Brian J. Druker, Eleanor N. Fish, Ronald Hoffman and Leonidas C. Platanias, Experimental Hematology, 1/1/2000
Shahab Uddin, Beata Majchrzak, Pu-Chen Wang, Sanjiv Modi, Mohammad K. Khan, Eleanor N. Fish and Leonidas C. Platanias, Biochemical and Biophysical Research Communications, 1/1/2000
Yi-Hsiang Chen; Rei-Tsang Shiao; Jo-Mel Labayog; Sanjiv Modi; Donald Lavelle, Leukemia and Lymphoma, 1/1/1997
Join now to see all

Abstracts/Posters

Roger Lyons, MD, Thomas Cosgriff, MD, Sanjiv Modi, MD, Linda Lintz, BA, C.L. Beach, PharmD4, and Jay T. Backstrom, MD, MPH4, Blood, 1/1/2005
Sonali M. Smith, Barbara Pro, Scott Smith, Patrick Stiff, Eric Lester, Sanjiv Modi, Janet Dancey, Everett E. Vokes, Koen van Besien

Lectures

1/1/2016
1/1/2016
1/5/2015
1/20/2014
1/25/2012
1/18/2010
1/12/2010
1/16/2007
1/6/2004
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

SanjivSModiMD

Dr. Modi is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.